Cargando…

Identification of Cerebrospinal Fluid MicroRNAs Associated With Leptomeningeal Metastasis From Lung Adenocarcinoma

Background: Leptomeningeal metastasis (LM) has frequently been observed in patients with lung adenocarcinoma. So far, its diagnosis and disease course monitoring are still extremely difficult. Moreover, there is no effective treatment regimen for LM due to a lack knowledge on the molecular mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Zhenyu, Yang, Guozi, He, Hua, Gao, Pengxiang, Jiang, Tongchao, Chen, Yong, Zhao, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152668/ https://www.ncbi.nlm.nih.gov/pubmed/32328453 http://dx.doi.org/10.3389/fonc.2020.00387

Ejemplares similares

A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer
por: Pan, Zhenyu, et al.
Publicado: (2019)

Leptomeningeal metastasis from solid tumors: clinical features and its diagnostic implication
por: Pan, Zhenyu, et al.
Publicado: (2018)

Deep Learning-Based Classification of Cancer Cell in Leptomeningeal Metastasis on Cytomorphologic Features of Cerebrospinal Fluid
por: Yu, Wenjin, et al.
Publicado: (2022)

Case report: Cerebrospinal fluid-derived circulating tumor DNA diagnoses and guides the treatment of a lung adenocarcinoma case with leptomeningeal metastasis
por: Bai, Yujun, et al.
Publicado: (2022)

Exploratory Profiling of Extracellular MicroRNAs in Cerebrospinal Fluid Comparing Leptomeningeal Metastasis with Other Central Nervous System Tumor Statuses
por: Im, Ji Hye, et al.
Publicado: (2021)

Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics
por: Bönig, Lena, et al.
Publicado: (2019)

Thinprep plus Papanicolaou Stain Method Is More Sensitive than Cytospin-Coupled Wright Giems Stain Method in Cerebrospinal Fluid Cytology for Diagnosis of Leptomeningeal Metastasis from Solid Tumors
por: Pan, Zhenyu, et al.
Publicado: (2015)

Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single‐arm study
por: Pan, Zhenyu, et al.
Publicado: (2016)

Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis
por: Nie, Naifu, et al.
Publicado: (2022)

Effective Treatment With Afatinib of Lung Adenocarcinoma With Leptomeningeal Metastasis Harboring the Exon 18 p.G719A Mutation in the EGFR Gene Was Detected in Cerebrospinal Fluid: A Case Report
por: Ma, Chunhua, et al.
Publicado: (2020)

Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
por: Wang, Yongsheng, et al.
Publicado: (2021)

Leptomeningeal metastasis from hepatocellular carcinoma with other unusual metastases: a case report
por: Pan, Zhenyu, et al.
Publicado: (2014)

Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis
por: Zhang, Zhen, et al.
Publicado: (2017)

Regulation of Metastasis by microRNAs in Ovarian Cancer
por: Wang, Yongchao, et al.
Publicado: (2014)

Intrathecal pemetrexed combined with involved-field radiotherapy as a first-line intra-CSF therapy for leptomeningeal metastases from solid tumors: a phase I/II study
por: Pan, Zhenyu, et al.
Publicado: (2020)

Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
por: Noor Eddin, Ahmed, et al.
Publicado: (2023)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis
por: Yoo, Byong Chul, et al.
Publicado: (2017)

MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis
por: Rezaee, Aryan, et al.
Publicado: (2023)

Diagnostic Value of Cerebrospinal Fluid Level of Carcinoembryonic Antigen in Patients with Leptomeningeal Carcinomatous Metastasis
por: Kang, Sung Jin, et al.
Publicado: (2010)

Experimental Assessment of Leptomeningeal Metastasis Diagnosis in Medulloblastoma Using Cerebrospinal Fluid Metabolomic Profiles
por: Im, Ji Hye, et al.
Publicado: (2021)

Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing
por: Yang, Hainan, et al.
Publicado: (2022)

Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study
por: Mitsuya, Koichi, et al.
Publicado: (2019)

Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid
por: Liao, Pei-Ya, et al.
Publicado: (2022)

Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.
por: Hovestadt, A., et al.
Publicado: (1990)

Cerebrospinal Fluid Penetrance of Daratumumab in Leptomeningeal Multiple Myeloma
por: Zajec, Marina, et al.
Publicado: (2020)

Identification of Differential MicroRNAs in Cerebrospinal Fluid and Serum of Patients with Major Depressive Disorder
por: Wan, Yunqiang, et al.
Publicado: (2015)

Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases
por: Bai, Kaixuan, et al.
Publicado: (2023)

Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
por: Naidoo, Jarushka, et al.
Publicado: (2021)

Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases
por: Wu, Xi, et al.
Publicado: (2022)

Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
por: Bidarra, David, et al.
Publicado: (2019)

Transcriptomic and Functional Screens Reveal MicroRNAs That Modulate Prostate Cancer Metastasis
por: Rao, Srinivasa R., et al.
Publicado: (2020)

Prognostic significance of molecular characteristics of cerebrospinal fluid for non‐small cell lung cancer patients with leptomeningeal metastasis
por: Li, Ning, et al.
Publicado: (2019)

Expression of microRNAs in cerebrospinal fluid of dogs with central nervous system disease
por: Marioni-Henry, Katia, et al.
Publicado: (2018)

Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas
por: Zajdel, Michalina, et al.
Publicado: (2019)

Profile of Cerebrospinal microRNAs in Fibromyalgia
por: Bjersing, Jan L., et al.
Publicado: (2013)

Mannan-binding lectin in cerebrospinal fluid: a leptomeningeal protein
por: Reiber, Hansotto, et al.
Publicado: (2012)

Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis
por: Kim, Hye Seon, et al.
Publicado: (2019)

MicroRNAs in Ewing Sarcoma
por: Dylla, Layne, et al.
Publicado: (2013)

Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis
por: Liang, Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n12jtul7tnbr9dvnpbictf0c4v